Junior Group Leader
My group aims to develop new radioisotope-labelled compounds for the imaging of tumour biology.
Bart is CRUK Junior Group Leader based at the Oxford Institute for Radiation Oncology and has headed the Radiopharmaceuticals and Molecular Imaging group since early 2013.
Bart trained in analytical chemistry and radiochemistry at the Universities of Hasselt and Ghent, Belgium. He obtained his PhD in radiopharmaceutical sciences from the University of Ghent and spent several years at the University of Toronto as a post-doctoral fellow before joining the University of Oxford in 2007 as a postdoctoral researcher in Professor Kate Vallis’ group.
Group Alumni & Next Destinations
James Knight, Postdoctoral Researcher - Newcastle University
Poty S. et al, (2019)
Call to arms: need for radiobiology in molecular radionuclide therapy.
Terry SYA. et al, (2019), EJNMMI 2019 Editorial. In Press.
Dual-Isotope Imaging Allows In Vivo Immunohistochemistry using Radiolabelled Antibodies in Tumours.
KNIGHT JC. et al, (2019), Nuclear Medicine and Biology
Cornelissen B. et al, (2018), Eur J Nucl Med Mol Imaging, 45, 2442 - 2455
Wilson T. et al, (2018), J Nucl Med